Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

Drug Concentrations: Measurements

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

Measurement of Bioavailability: Pharmacokinetic Methods

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Estimating safe doses of perfluorooctane sulfonate (PFOS): an international collaboration.

Archives of toxicology·2025

Same author

Evaluation of a high-throughput in-vitro-to-in-vivo extrapolation (IVIVE) workflow for the prioritization of potential developmental toxicity of chemicals.

ALTEX·2025

Same author

Evaluation of the validity of a perfluorooctane sulfonic acid exposure reconstruction using a measured serum concentration among workers with a wide range of exposure.

Annals of work exposures and health·2024

Same author

Range of the perfluorooctanoate (PFOA) safe dose for human health: An international collaboration.

Regulatory toxicology and pharmacology : RTP·2024

Same author

Use of quantitative <i>in vitro</i> to <i>in vivo</i> extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols.

Frontiers in toxicology·2024

Same author

Critical considerations in the review of the toxicological evidence regarding the potential carcinogenicity of aspartame.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2023

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

Quantitative interpretation of human biomonitoring data.

Harvey J Clewell¹, Yu Mei Tan, Jerry L Campbell

¹The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709, USA. hclewell@thehamner.org

Toxicology and Applied Pharmacology

|July 1, 2008

Summary

Physiologically based pharmacokinetic (PBPK) modeling aids biomonitoring by reconstructing human exposure levels. This approach helps assess risks by comparing exposure distributions to toxicity data, clarifying the health implications of detected chemicals.

More Related Videos

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Related Experiment Videos

Last Updated: Jul 4, 2026

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Area of Science:

Environmental Health
Toxicology
Biomonitoring

Background:

Biomonitoring detects low concentrations of chemicals in human samples, posing interpretation challenges.
Relating measured biomarker levels to toxicity data from animal studies is difficult.
Increasing numbers of detected chemicals necessitate better risk assessment methods.

Purpose of the Study:

To review the application of pharmacokinetic modeling, specifically PBPK modeling, for interpreting human biomonitoring data.
To introduce a 'reverse dosimetry' approach for exposure reconstruction.
To provide context for risk characterization of observed chemical concentrations.

Main Methods:

Utilizing physiologically based pharmacokinetic (PBPK) modeling.
Implementing a 'reverse dosimetry' framework.
Estimating exposure distributions from biomarker concentrations.

Main Results:

PBPK modeling facilitates exposure reconstruction from biomonitoring data.
The reverse dosimetry approach estimates environmental exposure distributions.
This enables comparison of estimated exposures to established toxicity benchmarks.

Conclusions:

Pharmacokinetic modeling, particularly PBPK, is crucial for interpreting biomonitoring data.
Reverse dosimetry provides a valuable tool for risk characterization.
This approach enhances the understanding of potential health risks associated with chemical exposures.